A once-daily pill for ulcerative colitis has delivered strong results in a clinical trial, easing symptoms even in patients ...

First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapiesTopline safety, ...

People with ulcerative colitis, a form of IBD, who were taking the new drug Omvoh and achieved clinical remission after 1 ...

Once-daily oral obefazimod met the primary endpoint of clinical remission at 8 weeks in a highly refractory population of ...

Ulcerative colitis and colorectal cancer have a connection, but you can lower your risk of the latter through regular cancer ...

“Debilitating digestive issues dominated my life because I couldn’t go longer than a half hour without going to the bathroom,” says Katie. “I was forced to try to schedule meetings, lunches and other ...

The FDA has approved golimumab for the treatment of children with moderately to severely active ulcerative colitis who weigh ...

Johnson & Johnson's Simponi gains FDA approval for treating pediatric ulcerative colitis, expanding options for young patients with this chronic condition.

Eli Lilly’s ulcerative colitis (UC) treatment, Omvoh (mirikizumab), has shown sustained positive outcomes in patients with ...

Crohn's disease and ulcerative colitis. Here's how to tell which one you have.

People with inflammatory bowel disease, like ulcerative colitis, are 2 to 3 times more likely to develop blood clots than ...

Ulcerative colitis happens when the immune system goes out of control and causes inflammation that can lead to tissue damage in the colon and rectum. Image Credit: iStock/Getty Images There’s no cure ...